跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MICAFUNGIN-AFT POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
MICAFUNGIN-AFT POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
Approved
THERAPEUTIC
MICAFUNGIN-AFT POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (CHINA)
🇸🇬 Health Sciences Authority
Approval Date
Jan 9, 2026
Approval ID
fc2e25627b35da97
Company
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (CHINA)
Type
Therapeutic
Approval Details
Approval Id
fc2e25627b35da97
Drug Name
MICAFUNGIN-AFT POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
Product Name
MICAFUNGIN-AFT POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
Approval Number
SIN17429P
Approval Date
2026-01-09
Registrant
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 9, 2026
Approval ID
fc2e25627b35da97
Type
Therapeutic
Back to HSA Approvals
